Reduced lung function at birth and the risk of asthma at 10 years of age

Geir Håland1, Karin C Lødrup Carlsen, Leiv Sandvik

  • 1Department of Pediatrics, Division of Woman and Child, Ullevål University Hospital, Oslo. geir.haland@medisin.uio.no

Insights

Reduced lung function in infancy, measured by the fraction of expiratory time (t(PTEF)/t(E)), predicts a higher risk of childhood asthma. This early indicator is crucial for identifying children prone to developing asthma by age 10.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Medicine
  • Epidemiology

Background:

  • Early infancy reduced lung function is linked to later obstructive airway diseases.
  • This study investigates if neonatal lung function predicts asthma development by age 10.

Purpose of the Study:

  • To assess the predictive value of early-life lung function measurements for childhood asthma.
  • To determine if reduced lung function shortly after birth is associated with asthma at 10 years of age.

Main Methods:

  • Prospective birth cohort study of 802 healthy infants.
  • Measured lung function using tidal breathing flow-volume loops (t(PTEF)/t(E)) and passive respiratory mechanics (compliance) shortly after birth.
  • Reassessed 616 children at age 10 with lung function tests, bronchial hyperresponsiveness (methacholine challenge), and asthma history interviews.

Main Results:

  • Infants with lower t(PTEF)/t(E) at birth had significantly higher rates of asthma history (24.3% vs. 16.2%) and current asthma (14.6% vs. 7.5%) at age 10.
  • Lower respiratory system compliance at birth also correlated with increased asthma history and current asthma.
  • Reduced lung function at birth showed a weak correlation with maximal midexpiratory flow rate at age 10.

Conclusions:

  • Reduced lung function in early infancy is a significant predictor of asthma development by age 10.
  • Early lung function parameters, particularly t(PTEF)/t(E), can identify infants at increased risk for childhood asthma.
Abstract

Related Concept Videos

Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...